×
About 43,021 results

ALLMedicine™ Venous Thromboembolism Center

Research & Reviews  19,827 results

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccinati...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097496
BMJ (Clinical Research Ed.); Pottegård A, Lund LC et. al.

May 6th, 2021 - To assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and to compare them with rates observed in the general populations. Population base...

Thromboembolic Complications of Vascular Catheters Used for Pediatric Continuous Renal ...
https://doi.org/10.1097/PCC.0000000000002754
Pediatric Critical Care Medicine : a Journal of the Socie... Szeps I, Östlund Å et. al.

May 5th, 2021 - Pediatric venous thromboembolic events are commonly associated with in situ central venous catheters. The risk for severe venous thromboembolism increases if a larger portion of the vessel lumen is occupied by the central venous catheter. A functi...

The safety and effectiveness of salvianolate in preventing perioperative venous thrombo...
https://doi.org/10.1097/MD.0000000000025639
Medicine Chai YN, Luo M et. al.

May 5th, 2021 - Salvianolate, a common drug for stabilizing heart disease and Angina Pectoris, is considered to be off-label for preventing venous thromboembolism (VTE) or anticoagulation at present. However, many clinical studies have showed that salvianolate ca...

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thr...
https://doi.org/10.1177/10760296211014575
Clinical and Applied Thrombosis/hemostasis : Official Jou... Dempfle CE, Koscielny J et. al.

May 4th, 2021 - We analyzed data for women who received fondaparinux for ≥7 days during pregnancy. The study retrospectively included women who received fondaparinux pre-, peri- and/or postpartum for ≥7 days for prophylaxis/venous thromboembolism (VTE) treatment ...

Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident ve...
https://doi.org/10.1055/a-1497-9777
Thrombosis and Haemostasis; Frischmuth T, Hindberg K et. al.

May 3rd, 2021 - The impact of the combination of obesity and multiple prothrombotic genotypes on venous thromboembolism (VTE) risk remains unclear. To investigate the joint effect of obesity and a genetic risk score (GRS) comprised of established prothrombotic si...

see more →

Guidelines  181 results

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy i...
https://doi.org/10.1016/j.jacc.2020.09.011
Journal of the American College of Cardiology; Kumbhani DJ, Cannon CP et. al.

Nov 30th, 2020 - 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Re...

Consensus-based clinical recommendations and research priorities for anticoagulant thro...
https://doi.org/10.1111/jth.15073
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Goldenberg NA, Sochet A et. al.

Nov 11th, 2020 - Observational studies indicate that children hospitalized with COVID-19-related illness, like adults, are at increased risk for venous thromboembolism (VTE). A multicenter phase 2 clinical trial of anticoagulant thromboprophylaxis in children hosp...

Scientific and Standardization Committee communication: Clinical guidance on the diagno...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283841
Journal of Thrombosis and Haemostasis : JTH; Spyropoulos AC, Levy JH et. al.

May 27th, 2020 - Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.|2020|Spyropoulos AC,Levy JH,Ageno W,Connors JM,Hunt BJ,|adminis...

Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, manage...
https://doi.org/10.1136/bmj.m1565
BMJ (Clinical Research Ed.); McCormack T, Harrisingh MC et. al.

May 20th, 2020 - Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing.|2020|McCormack T,Harrisingh MC,Horner D,Bewley S, ,|therapeutic use,standards,therapeutic use,drug therapy,epidemiology,therape...

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for...
https://doi.org/10.1016/j.ajog.2020.04.032
American Journal of Obstetrics and Gynecology; , Pacheco LD et. al.

May 3rd, 2020 - Venous thromboembolism is a major cause of maternal morbidity and mortality. The risk of venous thromboembolism is particularly elevated during the postpartum period and especially after cesarean delivery. There is considerable variation in the ap...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  21,097 results

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccinati...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097496
BMJ (Clinical Research Ed.); Pottegård A, Lund LC et. al.

May 6th, 2021 - To assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and to compare them with rates observed in the general populations. Population base...

Thromboembolic Complications of Vascular Catheters Used for Pediatric Continuous Renal ...
https://doi.org/10.1097/PCC.0000000000002754
Pediatric Critical Care Medicine : a Journal of the Socie... Szeps I, Östlund Å et. al.

May 5th, 2021 - Pediatric venous thromboembolic events are commonly associated with in situ central venous catheters. The risk for severe venous thromboembolism increases if a larger portion of the vessel lumen is occupied by the central venous catheter. A functi...

The safety and effectiveness of salvianolate in preventing perioperative venous thrombo...
https://doi.org/10.1097/MD.0000000000025639
Medicine Chai YN, Luo M et. al.

May 5th, 2021 - Salvianolate, a common drug for stabilizing heart disease and Angina Pectoris, is considered to be off-label for preventing venous thromboembolism (VTE) or anticoagulation at present. However, many clinical studies have showed that salvianolate ca...

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thr...
https://doi.org/10.1177/10760296211014575
Clinical and Applied Thrombosis/hemostasis : Official Jou... Dempfle CE, Koscielny J et. al.

May 4th, 2021 - We analyzed data for women who received fondaparinux for ≥7 days during pregnancy. The study retrospectively included women who received fondaparinux pre-, peri- and/or postpartum for ≥7 days for prophylaxis/venous thromboembolism (VTE) treatment ...

Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident ve...
https://doi.org/10.1055/a-1497-9777
Thrombosis and Haemostasis; Frischmuth T, Hindberg K et. al.

May 3rd, 2021 - The impact of the combination of obesity and multiple prothrombotic genotypes on venous thromboembolism (VTE) risk remains unclear. To investigate the joint effect of obesity and a genetic risk score (GRS) comprised of established prothrombotic si...

see more →

News  1,899 results

Addressing Women's Concerns About the J&J Vaccine
https://www.medscape.com/viewarticle/949384

Apr 15th, 2021 - A rare form of venous thromboembolism (VTE) has developed in premenopausal women who have received the Johnson & Johnson (J&J) SARS-CoV-2 vaccine. This week we learned that of the more than 6.8 million individuals in the United States who received...

Study Suggests No Added Risk of Blood Clots in COVID-19 Outpatients
https://www.medscape.com/viewarticle/948831

Apr 5th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The incidence of venous thromboembolism (VTE) in nonhospitalized patients with COVID-19 was not significantly different from patients without the ...

Doctors Debate Use of Blood Thinners to Prevent Clots in Women After C-Sections
https://www.medscape.com/viewarticle/947625

Mar 16th, 2021 - Nearly all women who deliver babies through cesarean section at Columbia University Irving Medical Center in New York City receive injections of the blood thinner heparin for weeks after the procedure, to prevent potentially life-threatening blood...

New ASH Guidelines: VTE Prevention and Treatment in Cancer Patients
https://www.medscape.com/viewarticle/946777

Mar 2nd, 2021 - New guidelines from the American Society of Hematology "strongly recommend" using no thromboprophylaxis over using parenteral thromboprophylaxis in ambulatory patients receiving cancer chemotherapy who have low venous thromboembolism (VTE) risk, a...

ACC Issues Guidance on Antithrombotic Therapy
https://www.medscape.com/viewarticle/943139

Dec 22nd, 2020 - The American College of Cardiology (ACC) has released a new Expert Consensus Decision Pathway (ECDP) on the use of anticoagulant and antiplatelet therapy in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) undergoing percutan...

see more →